By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: What’s Really Going on With Yaz
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > What’s Really Going on With Yaz
Policy & LawPublic Health

What’s Really Going on With Yaz

MadelineFerdinand
MadelineFerdinand
Share
3 Min Read
Yaz lawsuit
SHARE

Yaz lawsuit

An oral contraceptive known as Yaz has been cropping up in the news lately due to numerous impending lawsuits. If you’ve been curious as to what the hullabaloo is all about, listen up.

Yaz lawsuit

An oral contraceptive known as Yaz has been cropping up in the news lately due to numerous impending lawsuits. If you’ve been curious as to what the hullabaloo is all about, listen up.

More Read

Why My Patient Left the Office
Hospitals Get Early Start on Medicare Reform Sector
4 Healthcare Problems You Should Not Find in a Nursing Home
The Walking Gallery: Personalizing Patient Stories [Podcast]
Healthcare Is Part of Our Supply Chain: The Boeing Company

Yaz is a popular combination oral contraceptive containing estrogen and drospirenone, a new type of progestin hormone.  Drospirenone has a nasty habit of raising the potassium levels of some users to dangerously high levels, significantly increasing the risk of heart attack, blood clots and stroke. Users are who are overweight, diabetic or have high blood pressure are especially at risk for these dangerous side effects.

Because so many women throughout the country have suffered adverse effects from taking Yaz, the FDA recently updated the label for contraceptives containing drospirenone to warn that they may have a higher risk of blood clots.

While the potentially risky side effects of prescription drugs isn’t anything new to consumers, the behavior of Bayer Pharmaceuticals – the manufacturer of Yaz – has been called into question repeatedly. In 2008, a series of commercials exaggerated the approved uses of Yaz while neglecting to address the risks of the drug, prompting the FDA to write a warning letter to Bayer.

As a result, Bayer was required to create new commercials which clarified the drug’s side effects and official uses.

2009 brought a further citation against Bayer, this time for distributing low-quality batches of drosperinone to doctors and pharmacies. Bayer defended the shipments by stating that their standard procedure was to monitor the average quality of all shipments, not the quality of each individual batch.

The FDA issued yet another warning letter to Bayer accusing the company of using out-of-specification test results, mixing them with positive test results and reporting the average. Furthermore, the manufacturer was charged with having concealed results indicating that some batches of the drug were outside the company’s specifications.

Thanks to this rather shady behavior, victims have filed numerous lawsuits against Bayer, alleging their neglect in advertising the possible hazardous effects of Yaz resulted in serious injury.

If you’re looking to start a new oral contraceptive, make sure you discuss all health risks and concerns with your doctor. All birth control pills can increase the risk of blood clots, so it’s important to manage risk by staying heart healthy and quitting tobacco use.

Photo credit: Selbe B / Foter / CC BY-NC-ND

TAGGED:Yaz
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Breaking the Cycle: How Trauma-Informed Therapy Helps Survivors Rebuild Their Lives
Uncategorized
November 17, 2025
Nurse Education
Why Investing in Nurse Education Pays Dividends for the Entire Health System
Nursing
November 16, 2025
How In-Home Nursing Care Can Support Recovery After Surgery
M&Y Care LLC Explains How In-Home Nursing Care Can Support Recovery After Surgery
Nursing
November 11, 2025
health wellbeing Safe Home Heating for Vulnerable Populations: Children, Seniors, and Patients
Safe Home Heating for Vulnerable Populations: Children, Seniors, and Patients
Health
November 8, 2025

You Might also Like

Vermont Moves Closer to Single Payer Delivery

March 25, 2011

Mobile Health Around the Globe: Bonus Video! An Overview of Mobile Innovations

May 20, 2013
FDA LDT regulations
Policy & Law

Michael Little Offers Insights on FDA’s 2014 Regulations for LDTs

August 19, 2014
Image
Policy & Law

Pregnancy and Autonomy – Just Whose Body is it Anyway?

June 18, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?